Vertex to buy Crinetics for $10 billion in rare-diseases push - Reuters
Vertex to buy Crinetics for $10 billion in rare-diseases push Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxOX3N1NDFzcDNMSmVSODY1SEJGRm51Sl96QmtwWV9zMHA3RUZTRVlDenhJaG01alZQSU5KZUNWV2NFMFp6c0U5Xy1aZFZ2UXVmNWFGNk1HR1NMcGpJWHVpQjVtQWV2Z0FqMldWWHFwMlA2cHh1eDBtT19sem9BZ1ljblQta09WbWdBcjFzX3JVY2h2WlFsQ1VZ?oc=5" target="_blank">Vertex to buy Crinetics for $10 billion in rare-diseases push</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
RNA drug developer ADARx seeks $1.74 billion valuation in US IPO - Reuters
RNA drug developer ADARx seeks $1.74 billion valuation in US IPO Reuters
September 21, 2026 at 11:43 AMNanexa shares soar on €1.17 billion Novo Nordisk deal for injection technology - Reuters
Nanexa shares soar on €1.17 billion Novo Nordisk deal for injection technology Reuters
September 25, 2026 at 02:14 PMNvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on - Reuters
Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on Reuters
September 21, 2026 at 10:32 PMAI-based drug developer Basecamp valued at $800 million after $140 million funding round - Reuters
AI-based drug developer Basecamp valued at $800 million after $140 million funding round Reuters
September 23, 2026 at 01:08 PMAustralia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion - Reuters
Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion Reuters
September 20, 2026 at 11:01 PMWegovy maker Novo shares slump as management grilled on pricing, M&A - Reuters
Wegovy maker Novo shares slump as management grilled on pricing, M&A Reuters
September 21, 2026 at 01:21 PM